Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004336417 | SCV004056511 | uncertain significance | not specified | 2023-09-12 | criteria provided, single submitter | clinical testing | The c.1813C>T (p.R605C) alteration is located in exon 4 (coding exon 4) of the NPC1L1 gene. This alteration results from a C to T substitution at nucleotide position 1813, causing the arginine (R) at amino acid position 605 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |